Drugs / DTPa-HBV-IPV/Hib
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01457560 | Feb 2000 → Apr 2001 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, poliomyelitis +1 | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-HBV-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01457560 ↗ |
| Known as | Infanrix hexa | “combined DTPa-HBV-IPV/Hib (Infanrix hexa™) vaccine” NCT01457560 ↗ |
| Modality | Vaccine | “combined DTPa-HBV-IPV/Hib (Infanrix hexa™) vaccine” NCT01457560 ↗ |
| Route | Intramuscular | “Three doses administered intramuscularly” NCT01457560 ↗ |